MED

Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Total revenue 119 M115.73 M105.56 M89.41 M75.1 M 385.79 M Gross profit 88.22 M84.25 M76.64 M62.16 M52.14 M 275.19 M Operating expenses 87.55 M85.89 M77.72 M66.85 M60.31 M 290.77 M Selling/general/admin expenses 87.51 M85.51 M77.71 M66.24 M59.94 M 289.4 M Research & development ————— — Operating income 708 K-1.26 M-1.07 M-4.08 M-7.8 M -14.21 M Non-Operating Income, Total 566 K1.79 M3.94 M1.42 M1.42 M 8.57 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 566 K1.3 M1.37 M1.43 M1.42 M 5.52 M Unusual income/expense —487 K2.57 M-2 0001 000 3.06 M Pretax income 1.27 M526 K2.88 M-2.66 M-6.38 M -5.64 M Equity in earnings ————— — Taxes 474 K1.3 M395 K-396 K11.74 M 13.03 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 800 K-772 K2.48 M-2.26 M-18.12 M -18.67 M Discontinued operations ————— — Net income 800 K-772 K2.48 M-2.26 M-18.12 M -18.67 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 800 K-772 K2.48 M-2.26 M-18.12 M -18.67 M Basic earnings per share (Basic EPS) 0.08-0.070.23-0.21-1.65 -1.7 Diluted earnings per share (Diluted EPS) 0.08-0.070.22-0.21-1.64 -1.7 Average basic shares outstanding 10.93 M10.95 M10.99 M10.99 M10.98 M 43.91 M Diluted shares outstanding 10.96 M10.95 M11.06 M10.99 M10.98 M 43.98 M EBITDA 3.85 M1.63 M2.97 M-1.24 M-4.71 M -1.34 M EBIT 670 K-1.65 M-1.07 M-4.69 M-8.18 M -15.59 M Cost of revenue 30.78 M31.48 M28.91 M27.25 M22.96 M 110.6 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 3.19 M3.28 M4.04 M3.45 M3.46 M 14.24 M